• gmp-verlag.de
  • GMP MANUAL Login
  • Shopping cart
Stay informed!

If you’d like to be regularly informed of the latest developments at Good Manufacturing Practices

 

>>> REGISTER for our free GMP Newsletter LOGFILE

Image

TOP 5 GMP Downloads

1. GDP Audit Checklist
More than 700 questions with reference to regulations for preparing and carrying out GDP audits.

 

2. GMP Audit Checklist
The GMP Audit Checklist works great for both sides - the auditor and the inspected company.

 

3. Quality Agreement
Defines framework conditions and processes between contract givers and contract acceptors in order to meet mandatory quality criteria.

 

4. Risk Management
Apart from factual content you will find many tables, examples, forms, which can be used in daily practice.

 

5. Documenting Process Validation – A Drugmaker’s Guide
Document process validation in a way that’s sure to satisfy – and impress – regulators.

 

Your benefits:

> no shipping costs
> no waiting period: if you choose payment by credit card you will receive an email with the download information immediately after payment.

 

>>> Click here to find more Downloads!

News about GMP/cGMP

2011-03-08

WHO Report: Inspections of API Manufacturers

Recently the WHO (World Health Organization) issued the first "Pharmaceuticals Newsletter" in 2011. It contains an interesting Report on WHO Inspection Activites of API (Active Pharmaceutical Ingredients) Manufacturers.

 

API manufacturing site inspections were started in 2003. An inspection team normally consists of a WHO inspector based in Geneva and a co-inspector appointed by the WHO from a Pharmaceutical Inspection Cooperation Scheme (PIC/S) member inspectorate. An inspector (or inspectors) from the National Drug Regulatory Authority of the country, in which the manufacturing site is located is invited to participate as an observer.

Statistics

Out of 126 API sites participating in PQ activities, 49 were accepted based on approval by PICS inspectorates and/or ICH countries, while 31 were inspected by WHO inspectors. Six of the inspected sites were found to operate at an unacceptable level of compliance with WHO GMP.

Key Observations of API inspections

Deficiencies observed during inspections of API sites have been mainly in materials management, documentation, cleaning and cross-contamination.

Outcome:

You can download the WHO "Pharmaceuticals Newsletter", Issue 1/ 2011. You find the complete report at page 12 et seqq.

Link:

WHO/ Newsletter

Comments
No comment has yet been written about this news.